Region:Asia
Author(s):Geetanshi
Product Code:KRAE1601
Pages:85
Published On:March 2026

By Type:The market is segmented into various types of sequencing services, including Whole Genome Sequencing, Targeted Sequencing, Metagenomic Sequencing, RNA Sequencing, and Others. Whole Genome Sequencing is currently the leading sub-segment due to its comprehensive analysis capabilities, which are essential for understanding complex microbial communities. Targeted Sequencing is also gaining traction, particularly in clinical applications where specific pathogens need to be identified. The demand for these services is driven by advancements in technology and the increasing need for personalized medicine.

By End-User:The market is categorized by end-users, including Academic Research Institutions, Pharmaceutical Companies, Clinical Laboratories, Biotechnology Firms, and Others. Academic Research Institutions dominate the market due to their focus on microbiome research and the need for advanced sequencing technologies. Pharmaceutical companies are also significant users, leveraging microbiome data for drug development and personalized medicine. The increasing collaboration between academia and industry is further driving the demand for sequencing services.

The Thailand Microbiome Sequencing Outsourcing Services Market is characterized by a dynamic mix of regional and international players. Leading participants such as BGI Group, Illumina, Inc., Thermo Fisher Scientific, Novogene Co., Ltd., Macrogen, Inc., QIAGEN N.V., Genomatix Software GmbH, Zymo Research Corp., Oxford Nanopore Technologies, Roche Sequencing Solutions, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Inc., Ginkgo BioWorks, Genomatix Software GmbH contribute to innovation, geographic expansion, and service delivery in this space.
The future of the microbiome sequencing outsourcing services market in Thailand appears promising, driven by increasing investments in healthcare innovation and research. As the government allocates more funding towards microbiome studies, collaboration between academic institutions and private companies is expected to flourish. Additionally, the integration of artificial intelligence in data analysis will enhance the efficiency and accuracy of sequencing, paving the way for novel therapeutic approaches and improved patient outcomes in the coming years.
| Segment | Sub-Segments |
|---|---|
| By Type | Whole Genome Sequencing Targeted Sequencing Metagenomic Sequencing RNA Sequencing Others |
| By End-User | Academic Research Institutions Pharmaceutical Companies Clinical Laboratories Biotechnology Firms Others |
| By Application | Disease Diagnosis Drug Development Nutritional Analysis Environmental Monitoring Others |
| By Sample Type | Stool Samples Blood Samples Saliva Samples Tissue Samples Others |
| By Region | Central Thailand Northern Thailand Northeastern Thailand Southern Thailand |
| By Technology | Illumina Sequencing Ion Torrent Sequencing PacBio Sequencing Nanopore Sequencing Others |
| By Research Focus | Microbial Ecology Human Health Agricultural Microbiomes Industrial Applications Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Clinical Microbiome Applications | 100 | Clinical Researchers, Healthcare Practitioners |
| Pharmaceutical R&D | 80 | Pharmaceutical Scientists, R&D Managers |
| Academic Research Institutions | 70 | University Professors, Research Fellows |
| Biotechnology Firms | 90 | Business Development Managers, Product Managers |
| Healthcare Providers | 60 | Laboratory Directors, Pathologists |
The Thailand Microbiome Sequencing Outsourcing Services Market is valued at approximately USD 140 million, reflecting significant growth driven by factors such as chronic disease prevalence, personalized medicine awareness, and advancements in sequencing technologies.